Joshua Holter

BioAnalytical Scientist
Sangamo Therapeutics
Richmond, California

Researcher with 8+ years of BioAnalytical experience with multiple modalities of drug development. Experienced in bioanalytical assay strategy, including biomarker and immunogenicity assays associated with preclinical and clinical gene therapy programs.

Disclosure information not submitted.

Presentation(s):

• Assay Optimization to Detect Treatment-Boosted Neutralizing Anti-Transgene Antibodies in Patients

  Monday, October 17, 2022
  3:15 PM – 3:30 PM ET

• Detecting Species-Specific Cytosolic Transgene Protein Supporting Liver Gene Therapy Studies

  Monday, October 17, 2022
  3:45 PM – 4:00 PM ET